Stitcher
05-19-2009, 08:46 AM
Some items may require FREE registration to access.
If a URL does not work, please let me know so that I can fix it.
4834
Power3 Medical Announces Better Than Expected Results for Early Stage Diagnosis Capability of the NuroPro(R) PD Test for Parkinson's Disease
Interim Results From Clinical Validation Trials Underway in Greece and the U.S.
By: , Marketwire,May. 18, 2009 08:45 AM
http://uk.sys-con.com/node/966766
HOUSTON, TX -- (Marketwire) -- 05/18/09 -- Power3 Medical Products, Inc. (OTCBB: PWRM), announced today that results for the early stage diagnosis from clinical validation trials of the NuroPro® PD test for Parkinson's disease are better than expected. The NuroPro PD test was developed to help clinicians distinguish patients with Parkinson's disease from "normal" individuals and patients with other neurological disorders. The NuroPro PD test, developed by Power3, utilizes a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability that a patient has Parkinson's disease. The test is intended to solve a critical challenge facing physicians, clinicians, and patients for a quick, early stage and accurate diagnosis of the debilitating disease known as Parkinson's.
NuroPro(R), The First Blood Serum Diagnostic Test To Be Available For Alzheimer's Disease, Demonstrates High Sensitivity And Specificity
Medical News Today, Article Date: 18 Aug 2008 - 2:00 PDT
http://www.medicalnewstoday.com/articles/118494.php
Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company specializing in the development and commercialization of diagnostic tests for early detection of breast cancer and neurodegenerative diseases, is providing an interim status report of its international validation study of the company's NuroPro® blood serum biomarker test for Alzheimer's disease.
Power3 is currently conducting a 300-patient clinical validation study of its NuroPro® blood serum test for Alzheimer's and Parkinson's disease in collaboration with Dr. Marwan Sabbagh, the Director of Clinical Research at the Cleo Roberts Center of Clinical Research at the Sun Health Research Institute (http://www.centerwatch.com/news-resources/research-centers/profile-details.aspx?ProfileID=1539) in Sun City, Arizona.
4834
Special protein helps maintain an efficient brain
EurekAlert!, University of Wisconsin-Madison, Public release date: 18-May-2009, Contact: Dian Land
http://www.eurekalert.org/pub_releases/2009-05/uow-sph051809.php
MADISON — The instruction manual for maintaining an efficient brain may soon include a section on synaptotagmin-IV (Syt-IV), a protein known to influence learning and memory, thanks to a study by University of Wisconsin-Madison researchers.
The study showed that Syt-IV keeps the strength of synapses — connections between nerve cells where communication occurs — within a useful range of neither too strong nor too weak.
Synapses' ability to adjust over time by becoming bigger and stronger or smaller and weaker — their plasticity — is at the heart of remembering, forgetting and learning. A delicate balance is required for this optimal brain plasticity.
The study appears in Nature Neuroscience's advanced online publication on May 17.
4834
Victorian Invention a Watchful Approach to Parkinson's
Yahoo Finance!, On Monday May 18, 2009, 12:30 pm EDT
http://finance.yahoo.com/news/Victorian-Invention-a-bw-15279207.html?.v=1
ATLANTA--(BUSINESS WIRE)--Victoria, Australia researchers have developed a wristwatch that continuously monitors the health status of people with Parkinson’s disease to help doctors manage their treatment, Victorian Minister for Innovation Gavin Jennings said today.
The wristwatch, which is still at the prototype stage, was introduced onto the world market by Mr. Jennings at the 2009 BIO International Convention in Atlanta, USA.
4834
Former NBA forward Grant reveals he is battling Parkinson's disease
Sports Illustrated, By The Associated Press, Posted: Monday May 18, 2009 9:33PM; Updated: Monday May 18, 2009 9:33PM
http://sportsillustrated.cnn.com/2009/basketball/nba/05/18/Grant.Parkinsons.ap/index.html?eref=si_topstories
Former NBA forward Brian Grant revealed Monday that he has Parkinson's disease and is starting a Web site devoted to his fight with the neurological disorder.
The 37-year-old Grant told ESPN.com that he was diagnosed in January with "young onset Parkinson's" and began having tremors in his left hand last summer. He consulted two other well-known Parkinson's suffers, Michael J. Fox and Muhammad Ali, and quickly implemented several lifestyle changes.
4834
If a URL does not work, please let me know so that I can fix it.
4834
Power3 Medical Announces Better Than Expected Results for Early Stage Diagnosis Capability of the NuroPro(R) PD Test for Parkinson's Disease
Interim Results From Clinical Validation Trials Underway in Greece and the U.S.
By: , Marketwire,May. 18, 2009 08:45 AM
http://uk.sys-con.com/node/966766
HOUSTON, TX -- (Marketwire) -- 05/18/09 -- Power3 Medical Products, Inc. (OTCBB: PWRM), announced today that results for the early stage diagnosis from clinical validation trials of the NuroPro® PD test for Parkinson's disease are better than expected. The NuroPro PD test was developed to help clinicians distinguish patients with Parkinson's disease from "normal" individuals and patients with other neurological disorders. The NuroPro PD test, developed by Power3, utilizes a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability that a patient has Parkinson's disease. The test is intended to solve a critical challenge facing physicians, clinicians, and patients for a quick, early stage and accurate diagnosis of the debilitating disease known as Parkinson's.
NuroPro(R), The First Blood Serum Diagnostic Test To Be Available For Alzheimer's Disease, Demonstrates High Sensitivity And Specificity
Medical News Today, Article Date: 18 Aug 2008 - 2:00 PDT
http://www.medicalnewstoday.com/articles/118494.php
Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company specializing in the development and commercialization of diagnostic tests for early detection of breast cancer and neurodegenerative diseases, is providing an interim status report of its international validation study of the company's NuroPro® blood serum biomarker test for Alzheimer's disease.
Power3 is currently conducting a 300-patient clinical validation study of its NuroPro® blood serum test for Alzheimer's and Parkinson's disease in collaboration with Dr. Marwan Sabbagh, the Director of Clinical Research at the Cleo Roberts Center of Clinical Research at the Sun Health Research Institute (http://www.centerwatch.com/news-resources/research-centers/profile-details.aspx?ProfileID=1539) in Sun City, Arizona.
4834
Special protein helps maintain an efficient brain
EurekAlert!, University of Wisconsin-Madison, Public release date: 18-May-2009, Contact: Dian Land
http://www.eurekalert.org/pub_releases/2009-05/uow-sph051809.php
MADISON — The instruction manual for maintaining an efficient brain may soon include a section on synaptotagmin-IV (Syt-IV), a protein known to influence learning and memory, thanks to a study by University of Wisconsin-Madison researchers.
The study showed that Syt-IV keeps the strength of synapses — connections between nerve cells where communication occurs — within a useful range of neither too strong nor too weak.
Synapses' ability to adjust over time by becoming bigger and stronger or smaller and weaker — their plasticity — is at the heart of remembering, forgetting and learning. A delicate balance is required for this optimal brain plasticity.
The study appears in Nature Neuroscience's advanced online publication on May 17.
4834
Victorian Invention a Watchful Approach to Parkinson's
Yahoo Finance!, On Monday May 18, 2009, 12:30 pm EDT
http://finance.yahoo.com/news/Victorian-Invention-a-bw-15279207.html?.v=1
ATLANTA--(BUSINESS WIRE)--Victoria, Australia researchers have developed a wristwatch that continuously monitors the health status of people with Parkinson’s disease to help doctors manage their treatment, Victorian Minister for Innovation Gavin Jennings said today.
The wristwatch, which is still at the prototype stage, was introduced onto the world market by Mr. Jennings at the 2009 BIO International Convention in Atlanta, USA.
4834
Former NBA forward Grant reveals he is battling Parkinson's disease
Sports Illustrated, By The Associated Press, Posted: Monday May 18, 2009 9:33PM; Updated: Monday May 18, 2009 9:33PM
http://sportsillustrated.cnn.com/2009/basketball/nba/05/18/Grant.Parkinsons.ap/index.html?eref=si_topstories
Former NBA forward Brian Grant revealed Monday that he has Parkinson's disease and is starting a Web site devoted to his fight with the neurological disorder.
The 37-year-old Grant told ESPN.com that he was diagnosed in January with "young onset Parkinson's" and began having tremors in his left hand last summer. He consulted two other well-known Parkinson's suffers, Michael J. Fox and Muhammad Ali, and quickly implemented several lifestyle changes.
4834